DaVita HealthCare (DVA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

DaVita Inc. DVA has been gaining from its business model. The optimism, led by a decent third-quarter 2025 performance and the overseas growth, is expected to contribute further. However, concerns ...

Shares of DaVita (NYSE: DVA) climbed 8.6% on Wednesday after the dialysis services company announced strong fourth-quarter 2023 results. DaVita's quarterly revenue grew 7.8% year over year to $3.15 ...

Shares of DaVita DVA have risen 115.5% in the past year, outperforming the Zacks Medical - Outpatient and Home Healthcare industry’s growth of 37.8% and the broader Zacks Medical sector’s return of 12 ...

Last year was a forgettable one for DaVita (NYSE: DVA) shareholders, but understandably so. The stock ended up losing 25% of its value in calendar 2025 due to a combination of a declining number of ...

DaVita disclosed the incident on Monday in a regulatory filing. The company said that on the previous Saturday, April 12, it was subject to a ransomware attack. When the attack was discovered by ...

DaVita has had an impressive run over the past six months as its shares have beaten the S&P 500 by 12.5%. The stock now ...

Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting results this Tuesday after market hours. Here’s what you need to ...

DaVita’s latest analyst update keeps the fair value estimate steady at US$151.71, while several firms are lifting their individual price targets by US$4 to US$30. Those higher targets are being framed ...

We recently compiled a list titled Buffett Stock Portfolio: Top 10 Stock Picks for 2024. In this article, we will look at where DaVita Inc. (NYSE:DVA) ranks among the top 10 stocks in Buffet’s ...